Literature DB >> 24105457

Isomorphic red blood cells using automated urine flow cytometry is a reliable method in diagnosis of bladder cancer.

Satoru Muto1, Syo-Ichiro Sugiura, Akiko Nakajima, Akira Horiuchi, Masahiro Inoue, Keisuke Saito, Shuji Isotani, Raizo Yamaguchi, Hisamitsu Ide, Shigeo Horie.   

Abstract

BACKGROUND: We aimed to identify patients with a chief complaint of hematuria who could safely avoid unnecessary radiation and instrumentation in the diagnosis of bladder cancer (BC), using automated urine flow cytometry to detect isomorphic red blood cells (RBCs) in urine.
METHODS: We acquired urine samples from 134 patients over the age of 35 years with a chief complaint of hematuria and a positive urine occult blood test or microhematuria. The data were analyzed using the UF-1000i (®) (Sysmex Co., Ltd., Kobe, Japan) automated urine flow cytometer to determine RBC morphology, which was classified as isomorphic or dysmorphic. The patients were divided into two groups (BC versus non-BC) for statistical analysis. Multivariate logistic regression analysis was used to determine the predictive value of flow cytometry versus urine cytology, the bladder tumor antigen test, occult blood in urine test, and microhematuria test.
RESULTS: BC was confirmed in 26 of 134 patients (19.4 %). The area under the curve for RBC count using the automated urine flow cytometer was 0.94, representing the highest reference value obtained in this study. Isomorphic RBCs were detected in all patients in the BC group. On multivariate logistic regression analysis, only isomorphic RBC morphology was significantly predictive for BC (p < 0.001). Analytical parameters such as sensitivity, specificity, positive predictive value, and negative predictive value of isomorphic RBCs in urine were 100.0, 91.7, 74.3, and 100.0 %, respectively.
CONCLUSION: Detection of urinary isomorphic RBCs using automated urine flow cytometry is a reliable method in the diagnosis of BC with hematuria.

Entities:  

Mesh:

Year:  2013        PMID: 24105457     DOI: 10.1007/s10147-013-0623-9

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  38 in total

1.  Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part I: definition, detection, prevalence, and etiology.

Authors:  G D Grossfeld; M S Litwin; J S Wolf; H Hricak; C L Shuler; D C Agerter; P R Carroll
Journal:  Urology       Date:  2001-04       Impact factor: 2.649

2.  Evaluation of the Sysmex UF-1000i for the diagnosis of urinary tract infection.

Authors:  Jie Wang; Ying Zhang; DongWen Xu; Weijun Shao; Yuan Lu
Journal:  Am J Clin Pathol       Date:  2010-04       Impact factor: 2.493

3.  Benefits of the iQ200 automated urine microscopy analyser in routine urinalysis.

Authors:  Daan van den Broek; Irene M L W Keularts; Jos P M Wielders; Rob J Kraaijenhagen
Journal:  Clin Chem Lab Med       Date:  2008       Impact factor: 3.694

Review 4.  Evaluation of hematuria in adults.

Authors:  J M Sutton
Journal:  JAMA       Date:  1990-05-09       Impact factor: 56.272

5.  A blind controlled trial of phase-contrast microscopy by two observers for evaluating the source of haematuria.

Authors:  G Venkat Raman; L Pead; H A Lee; R Maskell
Journal:  Nephron       Date:  1986       Impact factor: 2.847

6.  Association of hematuria on microscopic urinalysis and risk of urinary tract cancer.

Authors:  Howard Jung; Joseph M Gleason; Ronald K Loo; Hetal S Patel; Jeff M Slezak; Steven J Jacobsen
Journal:  J Urol       Date:  2011-03-21       Impact factor: 7.450

7.  A new automated system for urine analysis: a simple, cost-effective and reliable method for distinguishing between glomerular and nonglomerular sources of haematuria.

Authors:  R N Kore; C S Dow; K M Desai
Journal:  BJU Int       Date:  1999-09       Impact factor: 5.588

8.  Diagnostic value of urinary dysmorphic erythrocytes in clinical practice.

Authors:  Meindert J Crop; Yolanda B de Rijke; Paul C M S Verhagen; Karlien Cransberg; Robert Zietse
Journal:  Nephron Clin Pract       Date:  2010-04-23

9.  Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples.

Authors:  B Cunderlíková; R Wahlqvist; A Berner; V Vasovic; T Warloe; J M Nesland; Q Peng
Journal:  Cytopathology       Date:  2007-04       Impact factor: 2.073

10.  Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection.

Authors:  Yair Lotan; Umberto Capitanio; Shahrokh F Shariat; Georg C Hutterer; Pierre I Karakiewicz
Journal:  BJU Int       Date:  2009-03-11       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.